Parceval Pharmaceuticals selects a Z-CARD® for its corporate brochure

ParcevalParceval Pharmaceuticals selected a PocketMedia Solutions’ Z-CARD – as opposed to other forms of traditional media – to promote its first cosmetic ingredient offering at a Paris trade show called In Cosmetics.

“I came across a Z-CARD a while ago and kept it because I was blown away by the clever design,” says Parceval Pharmaceuticals CEO Ulrich Feiter.

When it came time to look at a brochure design for Parceval Pharmaceuticals there was no doubt in his mind that the Z-CARD was the direction to take as it can be used as a quick reference tool when talking to prospective clients and also as a brochure for them to take home.

“For one thing, the Z-CARDs are unique and innovative – qualities Parceval identifies with. And, of course, we wanted something that was effective but also memorable – the Z-CARD fulfilled all of these requirements,” says Feiter.

“We haven’t done much traditional marketing in the past as we don’t really have a line of our own products, but rather facilitate the manufacturing of product ranges for other brands.  This was also our first trade show experience so we had to create a company brochure for the occasion.  The Z-CARD turned out better than we expected – we were thrilled with the result,” he adds.

“Our staff absolutely loved them. We also received numerous compliments from visitors to or stand, and even from competitor companies.”

“The service we received from PocketMedia Solutions was exceptional and well worth mentioning.  They went out of their way for us on a few occasions, and managed to deliver on the project given a very tight timeline,” Feiter confirms.

Parceval has over 20 years’ experience in manufacturing complimentary medicines and botanical extracts to Good Manufacturing Practice (GMP) standards.  With a network of transparent and regulatory-compliant supply chains in South Africa and across the continent, the company bridges Africa to the world, promoting the ethical use of her botanical riches.